Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Biolipox
About
Biolipox is a research-intense pharmaceutical company that develops new treatments for inflammatory diseases
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $41M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2000
- Operating Status
- Active
Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and inflammatory and rheumatic pain. The company offers its users with current arachidonic acid research. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. It is an established research area that empowers several drugs such as Aspirin, Naproxen, and Singulair.Biolipox is a Sweden-based company that was founded in 2000 and the company was acquired by Orexo on November 23, 2007.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 12, 2005 | Series C | $41M | 1 | — | — | Detail |
| Jan 15, 2003 | Series B | $21M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
